Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Researchers using CRISPR-Cas9 gene editing tools have discovered that while this technology can enhance T cell cancer therapies, it may also lead to unintended chromosomal loss in the edited immune ...

Since that discovery, a flurry of gene-editing focused biopharma companies have launched – including Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences and Mammoth Biosciences ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Beyond Casgevy, CRISPR Therapeutics continues ... In the realm of in vivo gene editing, CRISPR Therapeutics is progressing with programs such as CTX310 and CTX320, targeting cardiovascular diseases.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel Knockout Cells, an innovative product designed to revolutionize the field of ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...